Press Contact: email@example.com
Children’s National Hospital and the National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announce the six winners of the $150,000 “Make Your Medical Device Pitch for Kids!” competition, each receiving a $25,000 award and the opportunity to participate in NCC-PDI’s recently launched “Pediatric Device Innovator Accelerator Program” led by MedTech Innovator. The six winners, who […]
“Innovation plays an integral role when it comes to conduct in pediatric device trials. There are alternative methods to trials, such as data extrapolation from adult studies. If we can be well informed when mining that data, we shouldn’t put kids at risk and delay time to market.”
“Congratulations to these outstanding innovators and startup companies for developing pioneering medical devices that can advance NICU care,” says Kurt Newman, M.D., president and CEO of Children’s National Hospital.
Six winners were named in a pitch competition for medical devices designed to improve care in the neonatal intensive care unit at the seventh annual Pediatric Device Innovation Symposium, hosted by Washington, D.C.-based Children’s National Hospital.
Kolaleh Eskandanian, PhD, is the vice president and chief innovation officer of Children’s National Health System in Washington, D.C. Here, Dr. Eskandanian outlines the big cybersecurity challenges and how she expects her role as the chief innovation officer at Children’s National to evolve over the next few years.
While medical device innovation is quite active—at the university level, within incubators, and even in the R&D labs of established firms—there is a substantial lack of products being developed for younger patients. Since pediatric devices have a limited patient base due to most children being relatively healthy (of course, a positive factor), it’s not a […]
While FY2017’s approvals notably served all four pediatric age groups, the majority of pediatric devices approved over the last decade are not indicated for children under the age of 12. What’s more, a large portion of the devices indicated for FDA’s ‘adolescents’ category are only authorized for use in patients 18 or older.
The investment will fund the company’s pilot study through the activities needed to support the submission of an FDA IDE application for its pivotal trial. To date, the firm said it has raised more than $59 million in funding.
Developing medical devices in general is costly, but there is funding available for companies that are willing to create products specifically for pediatrics.
Seattle-based Bardy Diagnostics, Inc., a provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (CAM), a P-wave centric ambulatory cardiac monitor and arrhythmia detection device, announces that it was selected as one of six winners of the “Make Your Medical Device Pitch for Kids!” Competition hosted by the Sheikh […]